Circle Pharma
South San Francisco, California, United States · Healthcare, Health Care
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Key facts
- Headquarters
- South San Francisco, California, United States
- Employees
- 41
- Industries
- Healthcare, Health Care
- Status
- Private
- Website
- circlepharma.com
- Company page
Recent activity at Circle Pharma
- : Circle Pharma Appoints Marie Evangelista as Chief Scientific Officer
- : Circle Pharma announces $92.5 million Series E financing led by The Column Group to advance their Cyclin D1 program into clinical development.
- : Circle Pharma Appoints Rob Lauzen as Chief Financial Officer
- : Circle Pharma
- : Circle Pharma Launches Phase 1 Clinical Trial of CID-078, an Innovative Oral Cyclin A/B RxL Inhibitor for Advanced Solid Tumors.
- : Circle Pharma Announces Appointment of Marie Evangelista as Senior Vice President and Head of Cancer Biology, and Constantine Kreatsoulas as Senior Vice President and Head of Discovery Technology Sciences
- : Circle Pharma
- : Circle Pharma
- : Circle Pharma strengthens its executive leadership team with two senior appointments in Clinical Development
- : Circle Pharma, Inc.
Circle Pharma funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Series E | $92.5M |
| Jul 2024 | Venture | $54.2M |
| Jun 2021 | Venture | $35.7M |
| Jun 2021 | Series C | $66.0M |
| Mar 2020 | Venture | $92.4M |
Leadership
- David Earp, Executive Officer, Director
- John Josey, Director
- James Evangelista, Director
- Matthew Jacobson, Director
- Thilo Schroeder, Director
- Walter Moos, Director
- Peter Svennilson, Director
Verified email and direct lines for Circle Pharma’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Circle Pharma files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Circle Pharma in the news
- Boehringer Ingelheim collaborates with Circle Pharma - Boehringer Ingelheim (Oct 09, 2024)
- Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Business Wire (Oct 23, 2025)
- Press Release Service: Circle Pharma’s first-in-class orally bioavailable macrocyclic cyclin A/B inhibitors highlighted in poster presentations at American Association for Cancer Research Annual Meeting - CRISPR Medicine News (Apr 20, 2023)
- Circle Pharma Announces $92.5 Million Series E Financing to Advance First-in-class Cyclin D1 Program into Clinical Development - Business Wire (Sep 16, 2026)
- Circle Pharma Strengthens Leadership Team with Promotion of Marie Evangelista, Ph.D., to Chief Scientific Officer and Addition of Mary Ellen Sillivos as SVP and Head of Human Resources - Business Wire (Sep 28, 2026)
- Circle Pharma Announces Nomination of CID-165, an Oral First-in-class Cyclin D1 RxL Inhibitor, as Development Candidate for its Second Oncology Program - Business Wire (Dec 17, 2025)
- Circle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer - Business Wire (Jun 16, 2025)
- Circle Pharma Expands Leadership Team to Drive the Development of Its Pipeline of Oral Macrocycle Therapies - Business Wire (Sep 16, 2024)
Companies similar to Circle Pharma
- Exsilio Therapeutics · Healthcare, Health Care
- ImmersiveTouch · Healthcare, Health Care
- SpyGlass Pharma, Inc. · Healthcare, Health Care
- Vektor Medical · Healthcare, Health Care
- Latitude Food Allergy Care · Healthcare, Health Care
About Circle Pharma: questions and answers
What does Circle Pharma do?
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Where is Circle Pharma headquartered?
Circle Pharma is headquartered in South San Francisco, California, United States.
How many employees does Circle Pharma have?
Circle Pharma has about 41 employees.
Has Circle Pharma raised funding?
Yes. Fundz has recorded 5 funding events for Circle Pharma. The most recent, Series E of $92.5M, was in Sep 2026.
What is the latest news on Circle Pharma?
On Sep 28, 2026, Circle Pharma Appoints Marie Evangelista as Chief Scientific Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy